Research Interests

Dr. Ricke’s research interests include prostate cancer.

Recent Publications

• Ewald JA, Downs TM, Cetnar JP, Ricke WA. Expression microarray meta-analysis identifies genes associated with Ras/MAPK and related pathways in progression of muscle-invasive bladder transition cell carcinoma. PLoS ONE 2013; 8(2):e55414.
  [PubMed ID: 23383328, PMCID: 3562183]
  More Information
• Nicholson TM, Ricke EA, Marker PC, Miano JM, Mayer RD, Timms BG, vom Saal FS, Wood RW, Ricke WA. Testosterone and 17β-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male mice. Endocrinology 2012 Nov; 153(11):5556-65.
  [PubMed ID: 22948219, PMCID: 3473198]
  More Information
• Ricke EA, Williams K, Lee YF, Couto S, Wang Y, Hayward SW, Cunha GR, Ricke WA. Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis. Carcinogenesis 2012 Jul; 33(7):1391-8.
  [PubMed ID: 22535887, PMCID: 3499049]
  More Information
• Lapek JD, McGrath JL, Ricke WA, Friedman AE. LC/LC-MS/MS of an innovative prostate human epithelial cancer (PHEC) in vitro model system. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2012 Apr 15; 893-894():34-42.
  [PubMed ID: 22425387, PMCID: 3322323]
  More Information
• Ricke WA, Macoska JA, Cunha GR. Developmental, cellular and molecular biology of benign prostatic hyperplasia. Differentiation 2011 Nov-Dec; 82(4-5):165-7.
  [PubMed ID: 21880411, PMCID: 3415972]
  More Information
• Cunha GR, Ricke WA. A historical perspective on the role of stroma in the pathogenesis of benign prostatic hyperplasia. Differentiation 2011 Nov-Dec; 82(4-5):168-72.
  [PubMed ID: 21723032]
  More Information
• Nicholson TM, Ricke WA. Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation 2011 Nov-Dec; 82(4-5):184-99.
  [PubMed ID: 21620560, PMCID: 3179830]
  More Information
• Kohli M, Williams K, Yao JL, Dennis RA, Huang J, Reeder J, Ricke WA. Thrombin expression in prostate: a novel finding. Cancer Invest. 2011 Jan; 29(1):62-7.
  [PubMed ID: 21166500, PMCID: 3136353]
  More Information
• Ball LJ, Levy N, Zhao X, Griffin C, Tagliaferri M, Cohen I, Ricke WA, Speed TP, Firestone GL, Leitman DC. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements. Mol. Cell. Endocrinol. 2009 Feb 27; 299(2):204-11.
  [PubMed ID: 19059307, PMCID: 3420066]
  More Information
• Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke WA, Messing EM, Yao J, Yeh S, Chang C. Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 2008 Aug 26; 105(34):12182-7.
  [PubMed ID: 18723679, PMCID: 2527886]
  More Information